Benitec Limited, City of Hope Human Trial Update
Melbourne, Oct 23, 2008 (ABN Newswire) - Leading developer of RNA interference (RNAi)-based therapeutics Benitec Limited (ASX:BLT)(PINK:BNIKF) announced today that Dr John Zaia, had presented an update on the human HIV trial at the 2nd Annual Cambridge Healthtech Institute's "RNAi for Therapeutics" conference held in Boston, MA USA 22-23rd October 2008.